The Multiple Myeloma Hub are pleased to present a series of expert interviews from the 61st American Society of Hematology (ASH) meeting in Orlando, US. In this video, Jonathan L. Kaufman, Emory University, Atlanta, US, answers the question: Is venetoclax, in combination with dexamethasone, efficacious for patients with t(11;14) relapsed/refractory multiple myeloma? Jonathan Kaufman talks about the results of a study that examined the combination of venetoclax and dexamethasone in patients with t(11;14). He discusses the dosage regimen, safety, efficacy and overall response to the treatment.
0 Comments